This archive contains the following articles listed by volume, issue and page number:
 |
|
|
STABILITIES, COMPATIBILITIES RELATED ARTICLES |
Title (Click for Details) |
Vol/Issue |
Page |
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid |
Vol. 23 No. 6 |
504 |
Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt |
Vol. 23 No. 6 |
519 |
Stability of Furosemide 5 mg/mL in Polypropylene Syringes |
Vol. 23 No. 5 |
414 |
Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics |
Vol. 23 No. 5 |
434 |
Long-term Physicochemical Stability of Concentrated Solutions of Sodium Valproate in Polypropylene Syringes for Administration in the Intensive Care Unit |
Vol. 23 No. 4 |
320 |
Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients |
Vol. 23 No. 4 |
324 |
Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches |
Vol. 23 No. 4 |
340 |
An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability |
Vol. 23 No. 3 |
258 |
Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt |
Vol. 23 No. 2 |
157 |
Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit |
Vol. 23 No. 2 |
163 |
Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure |
Vol. 23 No. 2 |
167 |
Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets |
Vol. 23 No. 1 |
62 |
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt |
Vol. 23 No. 1 |
70 |
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) |
Vol. 22 No. 6 |
504 |
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
|
Vol. 22 No. 6 |
516 |
Stability of Tranexamic Acid Mouth Rinse |
Vol. 22 No. 5 |
412 |
Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags |
Vol. 22 No. 5 |
417 |
A Cold Process Preparation of Vetiveria zizanioides (L.) Nash Oil Lotions using Simulgel FL as an Emulsifier |
Vol. 22 No. 5 |
424 |
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension |
Vol. 22 No. 4 |
326 |
Kinetics of Tetracaine Solvolysis in Propylene Glycol |
Vol. 22 No. 4 |
329 |
Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit |
Vol. 22 No. 4 |
335 |
Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes |
Vol. 22 No. 4 |
340 |
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals |
Vol. 22 No. 3 |
240 |
Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations |
Vol. 22 No. 3 |
247 |
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia |
Vol. 22 No. 3 |
252 |
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions |
Vol. 22 No. 2 |
164 |
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension |
Vol. 22 No. 1 |
66 |
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection |
Vol. 22 No. 1 |
76 |
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride |
Vol. 22 No. 1 |
86 |
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid |
Vol. 21 No. 6 |
500 |
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes |
Vol. 21 No. 5 |
426 |
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt |
Vol. 21 No. 5 |
430 |
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags |
Vol. 21 No. 5 |
436 |
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox) |
Vol. 21 No. 4 |
322 |
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt |
Vol. 21 No. 4 |
334 |
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4 |
Vol. 21 No. 4 |
339 |
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia |
Vol. 21 No. 4 |
347 |
Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil |
Vol. 21 No. 3 |
240 |
Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes |
Vol. 21 No. 3 |
251 |
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions |
Vol. 21 No. 3 |
255 |
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers |
Vol. 21 No. 2 |
150 |
Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date |
Vol. 21 No. 2 |
154 |
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions |
Vol. 21 No. 2 |
160 |
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs |
Vol. 21 No. 2 |
164 |
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules |
Vol. 21 No. 2 |
171 |
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate |
Vol. 21 No. 1 |
66 |
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride |
Vol. 21 No. 1 |
76 |
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding |
Vol. 21 No. 1 |
83 |
Stability of Fentanyl Citrate in Polyolefin Bags |
Vol. 20 No. 6 |
514 |
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature |
Vol. 20 No. 6 |
521 |
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product |
Vol. 20 No. 5 |
416 |
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt |
Vol. 20 No. 5 |
421 |
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions |
Vol. 20 No. 5 |
426 |
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light |
Vol. 20 No. 5 |
435 |
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution |
Vol. 20 No. 5 |
438 |
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures |
Vol. 20 No. 4 |
328 |
Stability of Ampicillin in Normal Saline and Buffered Normal Saline |
Vol. 20 No. 4 |
338 |
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump |
Vol. 20 No. 4 |
343 |
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product |
Vol. 20 No. 4 |
347 |
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration |
Vol. 20 No. 3 |
236 |
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children |
Vol. 20 No. 3 |
247 |
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children |
Vol. 20 No. 3 |
257 |
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups |
Vol. 20 No. 2 |
159 |
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures |
Vol. 20 No. 2 |
164 |
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions |
Vol. 20 No. 2 |
167 |
Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care |
Vol. 20 No. 1 |
58 |
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation |
Vol. 20 No. 1 |
63 |
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date |
Vol. 20 No. 1 |
81 |
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment |
Vol. 19 No. 6 |
521 |
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules |
Vol. 19 No. 5 |
414 |
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF |
Vol. 19 No. 5 |
420 |
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures |
Vol. 19 No. 5 |
428 |
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers |
Vol. 19 No. 5 |
432 |
Stability of Prednisone in Oral Mix Suspending Vehicle |
Vol. 19 No. 4 |
337 |
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes |
Vol. 19 No. 4 |
344 |
Stability of Metronidazole Suspensions |
Vol. 19 No. 3 |
248 |
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials |
Vol. 19 No. 3 |
261 |
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles |
Vol. 19 No. 3 |
268 |
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration |
Vol. 19 No. 1 |
70 |
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions |
Vol. 19 No. 1 |
73 |
Stability of Suspensions: Theoretical and Practical Considerations before Compounding |
Vol. 19 No. 1 |
78 |
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils |
Vol. 18 No. 6 |
516 |
Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date |
Vol. 18 No. 4 |
345 |
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date |
Vol. 18 No. 4 |
348 |
Investigation of Physical and Chemical Stability of an Ointment with Herbals |
Vol. 18 No. 3 |
248 |
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date |
Vol. 18 No. 3 |
253 |
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery |
Vol. 18 No. 3 |
256 |
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride |
Vol. 18 No. 2 |
152 |
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets |
Vol. 18 No. 2 |
169 |
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C |
Vol. 18 No. 1 |
78 |
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles |
Vol. 17 No. 6 |
508 |
Stability of Nitroglyercin 100 mcg/mL Stored in Polypropylene Syringes |
Vol. 17 No. 6 |
515 |
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration |
Vol. 17 No. 5 |
436 |
Stability of Captopril in SyrSPend SF |
Vol. 17 No. 4 |
336 |
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry |
Vol. 17 No. 4 |
344 |
Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs |
Vol. 17 No. 4 |
347 |
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines |
Vol. 17 No. 3 |
238 |
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline |
Vol. 17 No. 3 |
254 |
Stability of Rifampin in SyrSpend SF |
Vol. 17 No. 2 |
162 |
Stability of Minoxidil in Espumil Foam Base |
Vol. 17 No. 2 |
165 |
Stability of Ursodiol in SyrSpend SF Cherry Flavored |
Vol. 16 No. 6 |
510 |
Stability of Propranolol Hydrochloride in SyrSpend SF |
Vol. 16 No. 6 |
513 |
Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations |
Vol. 16 No. 6 |
516 |
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date |
Vol. 16 No. 5 |
428 |
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets |
Vol. 16 No. 4 |
342 |
Stability of Gabapentin in SyrSpend SF |
Vol. 16 No. 4 |
347 |
Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste |
Vol. 16 No. 3 |
258 |
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) |
Vol. 16 No. 2 |
164 |
Stability of Vancomycin in SyrSpend SF |
Vol. 16 No. 2 |
167 |
Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method |
Vol. 16 No. 2 |
170 |
Chemical Stability of Pentoxifylline in a Topical Cream |
Vol. 16 No. 1 |
80 |
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration |
Vol. 16 No. 1 |
82 |
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags |
Vol. 15 No. 6 |
515 |
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions |
Vol. 15 No. 5 |
428 |
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations |
Vol. 15 No. 5 |
435 |
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate |
Vol. 15 No. 4 |
344 |
Stability of Ertapenem in an Elastomeric Infusion Device |
Vol. 15 No. 3 |
252 |
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles |
Vol. 15 No. 3 |
255 |
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations |
Vol. 15 No. 3 |
259 |
Nifedpine in Compounded Oral and Topical Preparations |
Vol. 15 No. 2 |
166 |
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes |
Vol. 15 No. 2 |
170 |
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs |
Vol. 15 No. 1 |
74 |
Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form |
Vol. 15 No. 1 |
78 |
Stability of Venlafaxine Immediate-Release Suspensions |
Vol. 15 No. 1 |
81 |
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date |
Vol. 14 No. 6 |
522 |
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study |
Vol. 14 No. 5 |
430 |
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device |
Vol. 14 No. 5 |
436 |
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping |
Vol. 14 No. 4 |
342 |
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin |
Vol. 14 No. 4 |
346 |
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration |
Vol. 14 No. 3 |
250 |
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector |
Vol. 14 No. 2 |
160 |
Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle |
Vol. 14 No. 1 |
76 |
Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam |
Vol. 14 No. 1 |
78 |
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) |
Vol. 14 No. 1 |
82 |
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes |
Vol. 13 No. 6 |
564 |
Chemical Stability of Scopolamine Hydrobromide Nasal Solution |
Vol. 13 No. 5 |
438 |
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms |
Vol. 13 No. 5 |
445 |
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding |
Vol. 13 No. 3 |
250 |
Stability of Pergolide Mesylate Oral Liquid at Room Temperature |
Vol. 13 No. 3 |
254 |
Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers |
Vol. 13 No. 2 |
162 |
Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions |
Vol. 13 No. 2 |
166 |
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule |
Vol. 13 No. 2 |
170 |
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration |
Vol. 13 No. 1 |
78 |
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution |
Vol. 12 No. 5 |
456 |
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration |
Vol. 12 No. 5 |
460 |
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration |
Vol. 12 No. 5 |
463 |
Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties |
Vol. 12 No. 6 |
550 |
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration |
Vol. 12 No. 6 |
553 |
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System |
Vol. 12 No. 6 |
558 |
Chemical Stability of Naltrexone Hydrochloride Injection |
Vol. 12 No. 3 |
274 |
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration |
Vol. 12 No. 3 |
276 |
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration |
Vol. 12 No. 2 |
156 |
Chemical Stability of Tramadol Hydrochloride Injection |
Vol. 12 No. 2 |
161 |
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting |
Vol. 12 No. 2 |
163 |
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration |
Vol. 12 No. 2 |
170 |
Room Temperature Stability of Injectable Succinylcholine Dichloride |
Vol. 12 No. 1 |
83 |
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration |
Vol. 11 No. 6 |
520 |
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion |
Vol. 11 No. 5 |
426 |
Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form |
Vol. 11 No. 4 |
347 |
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents |
Vol. 11 No. 3 |
259 |
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations |
Vol. 11 No. 2 |
164 |
Chemical Stability of Desonide in Ear Drops |
Vol. 11 No. 1 |
79 |
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration |
Vol. 11 No. 1 |
82 |
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions |
Vol. 10 No. 5 |
396 |
Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free |
Vol. 10 No. 4 |
318 |
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729> |
Vol. 10 No. 4 |
309 |
Stability of Memantine in an Extemporaneously Prepared Oral Liquid |
Vol. 10 No. 4 |
316 |
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration |
Vol. 10 No. 3 |
230 |
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration |
Vol. 10 No. 3 |
234 |
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together |
Vol. 10 No. 3 |
237 |
Chemical Stability of Diclofenac Sodium Injection |
Vol. 10 No. 2 |
154 |
Extended Stability of Oxytocin in Common Infusion Solutions |
Vol. 10 No. 2 |
156 |
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management |
Vol. 10 No. 1 |
69 |
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds |
Vol. 10 No. 1 |
74 |
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags |
Vol. 9 No. 6 |
482 |
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms |
Vol. 9 No. 6 |
484 |
Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration |
Vol. 9 No. 5 |
396 |
Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion |
Vol. 9 No. 5 |
399 |
Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations |
Vol. 9 No. 5 |
402 |
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration |
Vol. 9 No. 4 |
320 |
Stability of Nebulizer Admixtures |
Vol. 9 No. 4 |
323 |
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration |
Vol. 9 No. 3 |
235 |
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration |
Vol. 9 No. 3 |
238 |
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form |
Vol. 9 No. 2 |
165 |
Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature |
Vol. 9 No. 1 |
72 |
Stability of an Extemporaneously Compounded Propylthiouracil Suspension |
Vol. 9 No. 1 |
82 |
Stability of Extemporaneous Oral Ribavirin Liquid Preparation |
Vol. 8 No. 6 |
486 |
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink |
Vol. 8 No. 6 |
489 |
Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension |
Vol. 8 No. 6 |
492 |
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate |
Vol. 8 No. 5 |
398 |
Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags |
Vol. 8 No. 5 |
404 |
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. |
Vol. 8 No. 3 |
228 |
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. |
Vol. 8 No. 3 |
231 |
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. |
Vol. 8 No. 3 |
236 |
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution |
Vol. 8 No. 2 |
147 |
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion |
Vol. 8 No. 2 |
153 |
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags |
Vol. 8 No. 2 |
156 |
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours |
Vol. 8 No. 1 |
73 |
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder |
Vol. 7 No. 5 |
386 |
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride |
Vol. 7 No. 5 |
389 |
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets |
Vol. 7 No. 3 |
233 |
Stability of Clindamycin Phosphate in AutoDose Infusion System Bags |
Vol. 7 No. 2 |
149 |
Chemical Stability of Cefazolin Sodium after Reconstituting in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use |
Vol. 7 No. 2 |
152 |
Quantification of Total Dexamethasone Phosphate Delivery by Iontophoresis |
Vol. 7 No. 2 |
155 |
Stability of Glycopyrrolate Injection at Ambient Temperature and 4°C in Polypropylene Syringes |
Vol. 7 No. 1 |
65 |
Stability of Succinylcholine Chloride Injection at Ambient Temperature and 4 Degree C in Polypropylene Syringes |
Vol. 7 No. 1 |
68 |
Chemical Stability of Furosemide in Minibags and Polypropylene Syringes |
Vol. 6 No. 6 |
468 |
Stability of Neostigmine Methylsulfate Injection at Ambient Temperature and 4°C in Polypropylene Syringes |
Vol. 6 No. 6 |
475 |
pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes |
Vol. 6 No. 6 |
471 |
Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes |
Vol. 6 No. 5 |
388 |
Effect of Freezing, Long-Term Storage, and Microwave Thawing on the Stability of Cefepime in 5% Dextrose Infusion Polyvinyl Chloride Bags |
Vol. 6 No. 5 |
391 |
Chemical Stability of Dexamethasone Sodium Phosphate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes |
Vol. 6 No. 5 |
395 |
Stability of Tubocurarine Chloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes |
Vol. 6 No. 4 |
308 |
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs |
Vol. 6 No. 4 |
311 |
Stability of Ketamine Hydrochloride Injection After Reconstitution in Water for Injection and Storage in 1-mL Tuberculin Polypropylene Syringes for Pediatric Use |
Vol. 6 No. 4 |
316 |
Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags |
Vol. 6 No. 3 |
226 |
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs |
Vol. 6 No. 3 |
230 |
Stability of Cefotaxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use |
Vol. 6 No. 3 |
234 |
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags |
Vol. 6 No. 2 |
152 |
Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules |
Vol. 6 No. 2 |
155 |
Physical and Chemical Stability of Morphine Sulfate 5-mg/mL and 50-mg/mL Packaged in Plastic Syringes |
Vol. 6 No. 1 |
62 |
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes |
Vol. 6 No. 1 |
66 |
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes |
Vol. 6 No. 1 |
70 |
Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes |
Vol. 6 No. 1 |
74 |
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets |
Vol. 5 No. 6 |
480 |
Stability of Pentobarbital Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Repackaging in Glass and Polypropylene Syringes |
Vol. 5 No. 6 |
482 |
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes |
Vol. 5 No. 5 |
394 |
Assessment of the Stability of Teicoplanin in Intravenous Infusions |
Vol. 5 No. 5 |
397 |
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration |
Vol. 5 No. 4 |
314 |
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions |
Vol. 5 No. 4 |
323 |
Stability of Piperacillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use |
Vol. 5 No. 3 |
230 |
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid |
Vol. 5 No. 3 |
232 |
Chemical Stability of Methylprednisolone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes |
Vol. 5 No. 2 |
148 |
Stability of Cefepime Hydrochloride After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use |
Vol. 5 No. 2 |
151 |
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate |
Vol. 5 No. 2 |
153 |
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs |
Vol. 5 No. 1 |
69 |
Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use |
Vol. 5 No. 1 |
73 |
Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use |
Vol. 5 No. 1 |
75 |
Compatibility and Stability of Linezolid Injection Admixed with Gentamicin Sulfate and Tobramycin Sulfate |
Vol. 4 No .6 |
476 |
Stability of Nafcillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use |
Vol. 4 No .6 |
480 |
Stability of Levothyroxine Sodium Injection in Polypropylene Syringes |
Vol. 4 No .6 |
482 |
Stability of Hydrocortisone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use |
Vol. 4 No. 5 |
396 |
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets |
Vol. 4 No. 5 |
398 |
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs |
Vol. 4 No. 4 |
318 |
Stability of Morphine-Ketamine Mixtures in 0.9% Sodium Chloride Injection Packaged in Syringes, Plastic Bags and MEDICATION CASSETTEª Reservoirs |
Vol. 4 No. 3 |
225 |
Simple High-Performance Liquid Chromatographic Method for Simultaneous Determination of Fusidic Acid and Betamethasone Dipropionate in a Cream Formulation |
Vol. 4 No. 3 |
229 |
Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography |
Vol. 4 No. 3 |
233 |
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution |
Vol. 4 No. 2 |
146 |
Effect of Some Antioxidants on the Color Change of White Lotion |
Vol. 4 No. 2 |
154 |
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration |
Vol. 4 No. 2 |
150 |
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection |
Vol. 4 No. 1 |
66 |
Naratriptan HCl in Extemporaneously Compounded Oral Suspensions |
Vol. 4 No. 1 |
69 |
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids |
Vol. 4 No. 1 |
72 |
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C |
Vol. 3 No. 5 |
412 |
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II |
Vol. 3 No. 5 |
415 |
Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride |
Vol. 3 No. 3 |
235 |
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration |
Vol. 3 No. 3 |
241 |
Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography |
Vol. 3 No. 3 |
239 |
Analysis of Extemporaneous Alprostadil Formulations |
Vol. 3 No. 2 |
148 |
Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags |
Vol. 3 No. 2 |
156 |
Stability of Four Commercial Products Delivered by Mail Order |
Vol. 3 No. 1 |
59 |
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital |
Vol. 3 No. 1 |
64 |
Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature |
Vol. 3 No. 1 |
67 |
Chemical Stability of Meperidine Hydrochloride in Polypropylene Syringes |
Vol. 2 No. 6 |
463 |
Stability of Sufentanil in a Syringe Pump Under Simulated Epidural Infusion |
Vol. 2 No. 6 |
466 |
Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump |
Vol. 2 No. 5 |
382 |
Stability of Magnesium Sulfate in 0.9% Sodium Chloride and Lactated Ringers Solutions |
Vol. 2 No. 5 |
385 |
Stability of Albuterol in Continuous Nebulization |
Vol. 2 No. 5 |
394 |
The Stability of Amphotericin B in a Mixture of Fungizone and Optimoist |
Vol. 2 No. 4 |
311 |
Stability of Ciprofloxacin in Extemporaneous Oral Liquid Dosage Form |
Vol. 2 No. 4 |
314 |
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration |
Vol. 2 No. 4 |
318 |
Stability of Lorazepam in 5% Dextrose Injection |
Vol. 2 No. 4 |
322 |
Paclitaxel Compatibility with IV Express Filter Unit |
Vol. 2 No. 3 |
243 |
Stability of Milrinone Lactate in 5% Dextrose Injection and 0.9% Sodium Chloride Injection at Concentrations of 400, 600, 800 mcg/mL |
Vol. 2 No. 3 |
246 |
Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection |
Vol. 2 No. 2 |
168 |
Stability of Indomethacin in 0.9% Sodium Chloride Injection |
Vol. 2 No. 2 |
170 |
Physical Compatibility and Chemical Stability of Atracurium Besylate and Midazolam Hydrochloride during Intravenous Coinfusion |
Vol. 2 No. 1 |
79 |
Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane |
Vol. 2 No. 1 |
83 |
Stability of Mechlorethamine Hydrochloride 0.01% Ointment in Aquaphor® Base |
Vol. 2 No. 1 |
89 |
Stability of Two Concentrations of Heparin Sodium Prefilled in CADD-Micro Pump Syringes |
Vol. 1 No. 6 |
433 |
Stability of Cefepime Hydrochloride Dextrose in 5% Dextrose Injection and 0.9% Sodium Chloride Injection |
Vol. 1 No. 6 |
435 |
Short-Term Stability of Atenolol in Oral Liquid Formulations |
Vol. 1 No. 6 |
437 |
Stability of Clonazepam Suspension in HSC Vehicle |
Vol. 1 No. 6 |
440 |
Chemical Stability of Amiodarone Hydrochloride in Intravenous Fluids |
Vol. 1 No. 5 |
347 |
Some Quality Control Tests on Chromium Picolinate in Solid Dosage Forms |
Vol. 1 No. 5 |
349 |
The Stability of Lisinopril as an Extemporaneous Syrup |
Vol. 1 No. 5 |
352 |
Compatibility of Vancomycin Hydrochloride and Famotidine in 5% Dextrose Injection |
Vol. 1 No. 5 |
354 |
Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions |
Vol. 1 No. 5 |
356 |
Stability of Bethanechol Chloride Oral Liquid Dosage Forms |
Vol. 1 No. 4 |
278 |
Stability of Ceftriaxone Sodium When Mixed with Metronidazole Injection |
Vol. 1 No. 4 |
280 |
Stability of Mitomycin Aqueous Solution When Stored in Tuberculin Syringes |
Vol. 1 No. 4 |
282 |
The Formulation Development and Stability of Spironolactone Suspension |
Vol. 1 No. 3 |
195 |
The Formulation Development and Stability of Metronidazole Suspension |
Vol. 1 No. 3 |
200 |
Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections |
Vol. 1 No. 3 |
206 |
Stability of Cefmetazole Sodium in 5% dextrose Injection and 0.9% Sodium Chloride Injection |
Vol. 1 No. 3 |
208 |
The Compatibility of Common Respiratory Therapy Drug Combinations |
Vol. 1 No. 2 |
121 |
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs |
Vol. 1 No. 2 |
123 |
Quantitation of Metoprolol Tartrate and Propranolol Hydrochloride in Pharmaceutical Dosage Forms: Stability of Metoprolol in an Aqueous Mixture |
Vol. 1 No. 2 |
125 |
Stability of Allopurinol Suspension Compounded from Tablets |
Vol. 1 No. 2 |
128 |
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection |
Vol. 1 No. 2 |
132 |
Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion |
Vol. 1 No. 1 |
49 |
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets |
Vol. 1 No. 1 |
60 |